We are live on
!
Find out more
LC
Littlejohn & Co Portfolio holdings
AUM
$78.6M
1-Year Est. Return
1.93%
This Fund
S&P 500
This Quarter
Est. Return
-7.23%
1 Year Est. Return
+1.93%
3 Year Est. Return
+56.16%
5 Year Est. Return
+37.69%
10 Year Est. Return
–
AUM
$196M
AUM Growth
+$40.2M
(+26%)
Cap. Flow
+$48.5M
Cap. Flow
% of AUM
24.71%
Top 10 Holdings %
Top 10 Hldgs %
96.71%
Holding
37
New
3
Increased
5
Reduced
2
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Forward Air
FWRD
|
+$46.3M |
| 2 |
EEX
Emerald Holding
EEX
|
+$7.04M |
| 3 |
Alvotech
ALVO
|
+$1.34M |
| 4 |
Aveanna Healthcare
AVAH
|
+$1.31M |
| 5 |
MAGN
Magnera Corp
MAGN
|
+$966K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tenet Healthcare
THC
|
+$3.92M |
| 2 |
Insmed
INSM
|
+$1.36M |
| 3 |
SRG
Seritage Growth Properties
SRG
|
+$517K |
| 4 |
OSA
ProSomnus, Inc. Common Stock
OSA
|
+$47.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.49% |
| 2 | Real Estate | 22.72% |
| 3 | Industrials | 21.73% |
| 4 | Consumer Staples | 5.48% |
| 5 | Technology | 5.11% |
Similar funds
DCI
CMU
SPH
OIM
AOCA
GMEI
KC
CMANY
Littlejohn & Co's Q2 2024 Portfolio in Review
As of Q2 2024, Littlejohn & Co held 37 positions worth $196M, up 26% from $156M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
Littlejohn & Co deployed $48.5M of net new capital in Q2 2024, opening 3 new positions and adding to 5 existing holdings. Its largest new stake was Forward Air: 2,239,709 shares worth $42.6M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 41% a quarter earlier, followed by Real Estate and Industrials.
On the sell side, the largest reduction was Tenet Healthcare, an estimated $3.92M trimmed.
- Littlejohn & Co's largest Q2 2024 buy was Forward Air: 2,239,709 shares worth $42.6M.
- Littlejohn & Co added most to Alvotech in Q2 2024, an estimated $1.34M increase.
- Littlejohn & Co's biggest Q2 2024 reduction was Tenet Healthcare, cutting an estimated $3.92M.
- Littlejohn & Co fully exited Insmed in Q2 2024, selling an estimated $1.36M.
- Littlejohn & Co's ten largest holdings make up 97% of its $196M portfolio in Q2 2024.
- Littlejohn & Co opened 3 new positions and closed 7 in Q2 2024.
- Littlejohn & Co's portfolio value rose 26% quarter-over-quarter to $196M.
Based on Littlejohn & Co's 13F filing for Q2 2024, filed 13 Aug 2024.